Oncolytic Herpes Simplex Virus An Emerging Solution for Glioblastoma Glioblastoma (GBM) is one of the most aggressive and deadliest cancers with only few patients survive 2.5 years and less than 5% of patients survive 5 years following diagnosis 1 ....

Since June 2020, a webinar series known as Guerbet APAC TV so far has reached 81 countries/regions worldwide since it has been broadcasted. This year their 6 live webinars cover various topics in diagnostic imaging such as the application of artif...

Consolidation Therapy with Durvalumab “A revolutionary treatment of lung cancer has emerged in 2017. It is, durvalumab, a monoclonal antibody against programmed death ligand 1 (PD-L1). Physiologically, PD-L1 binds to its receptor programmed de...

Immune Checkpoint Inhibitor Therapy in Patients with Autoimmune Disorders: A Brief Review The clinical development of immune checkpoint inhibitors (ICIs), including those targeting the programmed cell death 1 and its ligand 1 (PD-1/PD-L1), or cytoto...

Advancement in Diagnostic Imaging for Early Detection of Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is the most common malignant tumour of the liver, whereas patients with HCC are often unaware of its presence until the tumour has progr...

Acute myeloid leukaemia (AML) accounts for approximately 80% of acute leukaemia diagnosed in adults and the 5-year overall AML survival rate is 15%. Mutational status of FMS-like tyrosine kinase 3 (FLT3) is now well recognised as delineating a subty...

The Applications of Oncolytic Virus in Cancer Therapy The observation of cancer remission after viral infection was reported in the early 1900s, which led to the hypothesis of treatment against cancer with virotherapy. In fact, there were clinical t...